Efficacy News and Research

RSS

Minor depression is effectively treated with medication

Minor depression, an underdiagnosed and undertreated subset of major depressive disorder that affects upwards of 15 million Americans, can be effectively treated with a drug called a selective serotonin reuptake inhibitor (SSRI)

5 Oct 2004

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

Pharmaceutical company, Merck Sharp & Dohme has announced an immediate voluntary world-wide withdrawal of the drug, Vioxx (rofecoxib), commonly used for patients with rheumatoid or osteoarthritis.

4 Oct 2004

FDA fast tracks Genaera's drug for the treatment of wet age-related macular degeneration

Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).

4 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

New research has opened up the prospect that gossypol – a drug refined from cottonseed oil and previously tried and abandoned as a male contraceptive – could boost the effectiveness of treatment for prostate tumours and possibly other common cancers as well.

30 Sep 2004

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Melbourne-based nanotechnology company Starpharma will lead a consortium to develop a second generation microbicide for the prevention of infection by HIV and other sexually transmitted diseases (STDs).

30 Sep 2004

Pine cones may form a new line of attack against MRSA infection

Pine cones may form a new line of attack against methicillin-resistant Staphylococcus aureus (MRSA) infection, the British Pharmaceutical Conference heard this week.

29 Sep 2004

Research confirms benefits of commonly used traditional remedies for a range of illnesses

Research presented to the British Pharmaceutical Conference today, confirms the benefits of commonly used traditional remedies for a range of illnesses, including cancer, offering a scientific justification for their use.

29 Sep 2004

New drug application to market ramelteon for insomnia

Takeda Global Research & Development Center announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) to market ramelteon (TAK-375), its investigational drug for insomnia.

26 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Limited, low-dose infusions of a widely used anesthetic drug may relieve the often intolerable and debilitating pain of Complex Regional Pain Syndrome (CRPS), a Penn State Milton S. Hershey Medical Center researcher found.

23 Sep 2004

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Pneumonia - one of the world’s deadliest diseases for young children in developing countries - could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin, with implications for better health outcomes and reduced costs

23 Sep 2004

Edible vaccine for HIV AIDS

Scientists from Novosibirsk are engaged in the development of an unusual vaccine which, apart from being less expensive to produce, safe and painless to administer, is also edible.

22 Sep 2004

University of Arizona spin-off investigates DNA damage to human skin

Niadyne, Inc., a Tucson-based spin-off biopharmaceutical company co-founded by two University of Arizona professors, has received a Small Business Innovation Research grant of nearly $750,000 to continue investigating the prevention of DNA damage to human skin

22 Sep 2004

Novel strategy for stimulating the production of utrophin

Researchers at the University of Pennsylvania School of Medicine report a novel strategy for stimulating the production of utrophin – an important muscle protein in young mice – for muscular dystrophy therapy.

21 Sep 2004

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

European positive for Cymbalta and Xeristar

Eli Lilly and Company and Boehringer Ingelheim have announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes.

20 Sep 2004

Efficacy News and Research

Minor depression is effectively treated with medication

Immediate voluntary world-wide withdrawal of Vioxx (rofecoxib)

FDA fast tracks Genaera's drug for the treatment of wet age-related macular degeneration

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Researchers show gossypol – a drug refined from cottonseed oil is a cancer treatment booster

Australian nanotech Starpharma to develop a second generation microbicide for the prevention of infection by HIV

Pine cones may form a new line of attack against MRSA infection

Research confirms benefits of commonly used traditional remedies for a range of illnesses

New drug application to market ramelteon for insomnia

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

Low-dose infusion of ketamine completely relieves pain of complex regional pain syndrome

Pneumonia could be treatable by the oral antibiotic amoxicillin rather than injectable penicillin

Edible vaccine for HIV AIDS

University of Arizona spin-off investigates DNA damage to human skin

Novel strategy for stimulating the production of utrophin

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

European positive for Cymbalta and Xeristar

Oral appliances effective in treating obstructive sleep apnea

A new lipid-based nasal ointment effective at reducing symptoms of allergic rhinitis

Researchers find palatal implants provide effective snoring relief

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News